CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

NCT06027957 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Non Hodgkin Lymphoma
B-Cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: anti-CD19 CAR T-cells

Sponsor

Vinmec Research Institute of Stem Cell and Gene Technology

Collaborators

[object Object]